Equifax Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-66.4% vs price
Base Case (Median)
-46.7% vs price
Bull Case (75th pct.)
-26.9% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $26.02 | -85.3% | High (40%) |
| PE Comparable | $110.09 | -37.7% | Medium (25%) |
| Growth Trajectory DCF | $94.15 | -46.7% | Medium (20%) |
| Graham Number | $69.17 | -60.9% | High (80%) |
| EV/EBITDA | $148.27 | -16.1% | Medium (20%) |
| EV/FCF | $179.38 | 1.5% | Medium (20%) |
| Earnings Power Value | $49.49 | -72.0% | High (70%) |
Based on 7 out of 8 methods, EFX appears overvalued at the current price of $176.80. The base case fair value of $94.15 implies 46.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.